Sionna Therapeutics recently secured an initial public offering (IPO) of $191m on the Nasdaq stock exchange, signalling ...

Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...

A brief history of Netflix stock. Netflix was founded in 1997 as a competitor to Blockbuster, operating a DVD-by-mail rental ...

Investing.com -- Maze Therapeutics Inc (NASDAQ: MAZE ) received bullish coverage from multiple analysts, with Guggenheim, ...

Basel Medical Group (NASDAQ:BMGL) shares were up 4% in late afternoon trading Tuesday following a $9M U.S. initial public ...

Mirae Asset Mutual Fund has launched four new investment schemes, catering to two distinct themes—Initial Public Offerings ...

The Sensex closed marginally higher on Tuesday, while the Nifty ended flat, as gains in heavyweight financial and auto stocks ...

CeriBell Inc (CBLL) reports a 41% revenue increase and strategic expansions, despite facing increased operating expenses and supply chain tariffs.

Paytm, Delhivery, and Honasa are the top losers, while Zomato and PB Fintech have stood up successfully against the market ...

Australia's securities regulator has urged the nation's stock exchange operator to be more proactive in making it easier and ...

Guggenheim analyst sees significant upside in Metsera stock to $56. MTSR is working on both injectable and oral weight-loss ...